TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 7,171 | 6,559 | 5,944 |
Financial expenses | 126 | 1 | 0 |
Earnings before taxes | -223 | 244 | 1,033 |
EBITDA | -98 | 247 | 1,034 |
Total assets | 2,712 | 3,154 | 2,394 |
Current assets | 2,375 | 3,134 | 2,382 |
Current liabilities | 1,197 | 1,352 | 2,265 |
Equity capital | 95 | 122 | 121 |
- share capital | 18 | 20 | 20 |
Employees (average) | 45 | 34 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 3.5% | 3.9% | 5.1% |
Turnover per employee | 159 | 193 | 220 |
Profit as a percentage of turnover | -3.1% | 3.7% | 17.4% |
Return on assets (ROA) | -3.6% | 7.8% | 43.1% |
Current ratio | 198.4% | 231.8% | 105.2% |
Return on equity (ROE) | -234.7% | 200% | 853.7% |
Change turnover | 1,144 | 725 | 2,031 |
Change turnover % | 19% | 12% | 52% |
Chg. No. of employees | 11 | 7 | 3 |
Chg. No. of employees % | 32% | 26% | 13% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.